Altucell, Inc. is a cellular engineering and biotech company backed by sound research and science focused on fulfilling a large "unmet need" in cell, molecular and regenerative therapy for treatment of Diabetes and other autoimmune and neurodegenerative diseases. The company's proprietary and unique technology overcomes the major barriers to transplantation by a novel strategy utilizing patented micro-encapsulation technology, enabling a transplantable, cell-based therapy that avoids detection and rejection by the immune system.
| Website | http://www.altucell.com |
| Revenue | $5 million |
| Employees | View employees |
| Address | 561 Acorn St Unit I, Deer Park, New York 11729, US |
| Phone | +1 631-586-4940 |
| Industry | Business Services General, Biotechnology, Business Services, Science and Engineering |
| Competitors | Tissue Regenix Group, Organogenesis, Acelity, Smith+Nephew, MediWound Ltd., Sangamo Therapeutics, Inc., Athersys, Receptos, a wholly-owned subsidiary of Celgene, Histogen Inc, Aptar Pharma +23 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies |
Looking for a particular Altucell employee's phone or email?
Altucell Questions
The Altucell annual revenue was $5 million in 2026.
Altucell is based in Deer Park, New York.
The NAICS codes for Altucell are [54171, 541, 54, 541713, 5417].
The SIC codes for Altucell are [87, 873].
